Evidence map›Paper›PMID 27965668›Full record

ArticleFrontiers in immunology2016

Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain.

Ricardo Calderon-Gonzalez, Hector Teran-Navarro, José María Marimon, Claudia González-Rico, Jorge Calvo-Montes, Elisabet Frande-Cabanes, Miriam Alkorta-Gurrutxaga, M C Fariñas, Luis Martínez-Martínez, Emilio Perez-Trallero and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. A Comparison Between RecombinantFrontiers in immunology · 2021
    Article
  3. Epitopes for Multivalent Vaccines AgainstFrontiers in cellular and infection microbiology · 2020
    Article
  4. Dendritic cell therapy in melanoma.Annals of translational medicine · 2017
    Review
  5. GNP-GAPDHOncotarget · 2017
    Article
  6. Article
  7. Impact of immunosuppression onPathogens and global health
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ricardo Calderon-GonzalezGrupo de Nanovacunas y vacunas celulares basadas en Listeria y sus aplicaciones en biomedicine, Instituto de Investigación Marqués de Valdecilla (IDIVAL) , Santander , Spain.
Hector Teran-NavarroGrupo de Nanovacunas y vacunas celulares basadas en Listeria y sus aplicaciones en biomedicine, Instituto de Investigación Marqués de Valdecilla (IDIVAL) , Santander , Spain.
José María MarimonServicio de Microbiología, Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastián, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Claudia González-RicoSección de Enfermedades Infecciosas, Hospital Universitario Marques de Valdecilla , Santander , Spain.
Jorge Calvo-MontesServicio de Microbiología, Hospital Universitario Marques de Valdecilla , Santander , Spain.
Elisabet Frande-CabanesGrupo de Nanovacunas y vacunas celulares basadas en Listeria y sus aplicaciones en biomedicine, Instituto de Investigación Marqués de Valdecilla (IDIVAL) , Santander , Spain.
Miriam Alkorta-GurrutxagaServicio de Microbiología, Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastián, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
M C FariñasSección de Enfermedades Infecciosas, Hospital Universitario Marques de Valdecilla, Santander, Spain; Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain.
Luis Martínez-MartínezServicio de Microbiología, Hospital Universitario Marques de Valdecilla, Santander, Spain; Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.
Emilio Perez-TralleroServicio de Microbiología, Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastián, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Carmen Alvarez-DominguezGrupo de Nanovacunas y vacunas celulares basadas en Listeria y sus aplicaciones en biomedicine, Instituto de Investigación Marqués de Valdecilla (IDIVAL) , Santander , Spain.
Instituto de Investigación Marqués de Valdecilla · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESMarqués de Valdecilla University Hospital · ESUniversidad de Cantabria · ESBiogipuzkoa Health Research Institute · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two regions of northern Spain, Gipuzkoa, and Cantabria present high annual incidence of listeriosis (1.86 and 1.71 cases per 100,000 inhabitants, respectively). We report that the high annual incidences are a consequence of infection with highly virulent

Indexed as

Listerialisteriosiszoonoses

Identifiers

PMID27965668
PMCPMC5126465
OpenAlexW2558585689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.